![Thomas F. Keller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas F. Keller
Direttore/Membro del Consiglio presso
Child Care Services Association
Profilo
Thomas F.
Keller is currently the Director at Child Care Services Association.
Prior to this, he was a Director at Biogen MA, Inc., DIMON, Inc., and Hatteras Income Securities, Inc. He also served as a Director at Biogen, Inc. In addition, he was a Professor at Duke University from 1974 to 2004.
From 1991 to 2008, he was a Director at Wendy's International LLC.
He was also a Director at Biogen Idec New Ventures, Inc. from 1996 to 2007.
Posizioni attive di Thomas F. Keller
| Società | Posizione | Inizio |
|---|---|---|
Child Care Services Association
 Child Care Services Association Services to the Health IndustryHealth Services Provides social services for children | Direttore/Membro del Consiglio | 13/11/2009 |
Precedenti posizioni note di Thomas F. Keller
| Società | Posizione | Fine |
|---|---|---|
Hatteras Income Securities, Inc.
 Hatteras Income Securities, Inc. Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Direttore/Membro del Consiglio | 23/03/2013 |
Wendy's International LLC
 Wendy's International LLC RestaurantsConsumer Services Operates fast food restaurants | Direttore/Membro del Consiglio | 29/09/2008 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Direttore/Membro del Consiglio | 31/12/2007 |
DIMON, Inc.
 DIMON, Inc. Wholesale DistributorsDistribution Services Purchases, stores, and sells leaf tobacco | Direttore/Membro del Consiglio | 16/05/2005 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2004 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
DIMON, Inc.
DIMON, Inc. Wholesale DistributorsDistribution Services Purchases, stores, and sells leaf tobacco | Distribution Services |
Hatteras Income Securities, Inc.
Hatteras Income Securities, Inc. Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
Wendy's International LLC
Wendy's International LLC RestaurantsConsumer Services Operates fast food restaurants | Consumer Services |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Child Care Services Association
Child Care Services Association Services to the Health IndustryHealth Services Provides social services for children | Health Services |
